Proteome: Proteome Sciences gives bullish outlook for 2025
Shares in drug development services group Proteome Sciences rose on Monday after the company said 2024 results should reflect a good recovery and that its pipeline is looking strong for next year.
Read full article »
Proteome Sciences is a life sciences company that engages in the research and development of novel protein biomarker for diagnosis of cancer.
Read more